hims compounded glp 1 & Hers stock drops 30% after Novo Nordisk terminates deal My research on $HIMS compounded

One of the key reasons patient advocates cite for preferring GLP-1 therapies, beyond clinical benefits, is their convenienceas these drugs are administered once weekly, unlike insulin, which requires daily injections

Potential risks may include: Overdosing, which may lead to symptoms such as nausea, vomiting, or other adverse effects

Additionally, proponents argue that even sub-therapeutic doses might provide modest improvements in appetite regulation and weight management outcomes that could benefit Hashimoto's patients struggling with metabolic complications

Advances in muscle health and nutrition: a toolkit for healthcare professionals